clinical research; coronavirus disease 2019; editorial; Flavivirus; gene therapy; genetic transduction; immune response; nonhuman; pseudotyping; publication; scientific literature; Severe acute respiratory syndrome coronavirus 2; virus; virus gene; virus genome; virus particle; virus recombinant; virus replication; neutralizing antibody/ec [Endogenous Compound]; vaccine; virus antibody/ec [Endogenous Compound]; virus vector; pseudotyped virus